MedTrace Logo

Effect of 6R-BH4 Treatment in Coronary Artery Disease (OXBIO Study)

NCT00423280 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 66

Last updated 2008-08-07

No results posted yet for this study

Summary

The purpose of this study is to determine the effect of 6R-BH4 on vascular function in patients with coronary artery disease. We hypothesize that 6R-BH4 will improve vascular function in these patients.

Conditions

Interventions

DRUG

6R-BH4

6R-BH4 tablets 700mg/day, 6R-BH4 tablets 400mg/day or placebo

Sponsors & Collaborators

Principal Investigators

  • Keith M Channon, MD FRCP · University of Oxford

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-11-30
Primary Completion
2009-02-28
Completion
2009-02-28

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00423280 on ClinicalTrials.gov